Chase brings nearly twenty years of healthcare senior leadership experience to Genomind. Prior to joining the team, Chase served as the SVP of Marketing & Sales Operations at IVX Health, a national provider of outpatient infusion centers, through its sale to private equity group Linden Capital in June 2024.

Prior to his time at IVX, Chase served as the Vice President of Marketing for NextGen Healthcare, overseeing its Product and Portfolio Marketing team for the $550 million healthcare technology and service provider. Prior to its sale to NextGen, Chase served on the leadership team at Entrada as its Chief Commercial Officer.

Chase graduated from the University of Tennessee and then earned an MBA from Vanderbilt’s Owen Graduate School of Management.